Herpes Zoster Infection Treatment Market to Grow with a CAGR of 3.89% through 2028
Rising ongoing advancements in treatment options is
expected to drive the Global Herpes Zoster Infection Treatment Market growth in
the forecast period, 2024-2028.
According to TechSci Research report, “Herpes
Zoster Infection Treatment Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Herpes
Zoster Infection Treatment Market stood at USD 248.92 million in 2022 and is
anticipated to grow with a CAGR of 3.89% in the forecast period, 2024-2028.
The Global
Herpes Zoster Infection Treatment Market has been experiencing substantial
growth in recent years, driven by a convergence of factors that have reshaped
the landscape of herpes zoster infection management. One of the most
significant drivers of the global herpes zoster infection treatment market is
the aging population. As the world's demographic structure evolves, with an
increasing number of individuals reaching their senior years, the risk of
herpes zoster infection rises significantly. This heightened susceptibility is
primarily attributed to a weakened immune system in older adults, making them
more prone to the reactivation of the varicella-zoster virus. The aging
demographic not only increases the incidence of herpes zoster but also drives
the demand for effective treatments. Elderly individuals experiencing shingles
often suffer from severe pain and discomfort, making them more likely to seek medical
attention and treatment. Consequently, the expanding aging population serves as
a consistent and reliable driver for the growth of the herpes zoster infection
treatment market.
Another crucial driver of the market is the increasing
awareness about herpes zoster infection among both healthcare professionals and
the general public. In the past, herpes zoster was often misdiagnosed or
misunderstood, leading to delayed treatment and inadequate management. However,
with the dissemination of medical knowledge and awareness campaigns, more
individuals are now able to recognize the symptoms of shingles and seek prompt
medical care. Advancements in the treatment of herpes zoster infection have
revolutionized patient care and further driven market growth. The availability
of antiviral medications, such as acyclovir, valacyclovir, and famciclovir, has
been instrumental in reducing the severity and duration of herpes zoster
symptoms. These medications are proven to be highly effective when administered
promptly after the onset of the infection. Additionally, pain management drugs,
including opioids and anti-inflammatory medications, have become integral
components of herpes zoster treatment. They help alleviate the excruciating
pain and discomfort associated with the condition, improving the overall
quality of life for patients.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Herpes Zoster Infection Treatment Market.”
Furthermore, the introduction of vaccines for herpes
zoster prevention has been a game-changer. Vaccines like Zostavax and Shingrix
have garnered substantial demand, especially among older adults who are most at
risk. The vaccination efforts have not only contributed to reducing the
incidence of herpes zoster but have also bolstered the market by offering a
preventive solution. The Global Herpes Zoster Infection Treatment Market is
segmented into Drugs, Route of administration, distribution channel, regional
distribution, and company.
Based on the Treatment Type, the Prescription
treatment emerged as the dominant
segment in the global market for Global Herpes Zoster Infection Treatment
Market in 2022. Prescription treatments for herpes zoster, including antiviral
medications (such as acyclovir, valacyclovir, and famciclovir) and targeted
therapies, have been clinically proven to be highly effective in reducing the
severity and duration of the infection. They are specifically designed to
target the varicella-zoster virus responsible for herpes zoster, helping to
control its replication and spread within the body. Prescription treatments for
herpes zoster are part of established medical guidelines and recommendations.
Healthcare professionals are trained to diagnose and manage herpes zoster, and
prescription medications are an integral part of the standard of care. This
widespread acceptance within the medical community reinforces the use of
prescription treatments. Compared to other treatment options like surgery or
radiation therapy, prescription treatments are non-invasive. Patients do not
need to undergo surgical procedures or radiation therapy, which may involve
more significant risks and complications. This non-invasiveness is often
preferred by patients and healthcare providers alike.
Based on the Distribution Channel, the Retail
pharmacies emerged as the dominant player in the global market for Global
Herpes Zoster Infection Treatment Market in 2022 Retail pharmacies are easily
accessible to the general population. They are typically located in urban and
suburban areas, making it convenient for patients to visit and obtain their
prescribed medications. This accessibility ensures that individuals have a
nearby source for herpes zoster infection treatments. Retail pharmacies have a
long-established presence in the healthcare landscape, and people are familiar
with their services. Patients often have established relationships with
pharmacists and trust the expertise and guidance they provide, which is
particularly important for a condition like herpes zoster.
North America emerged as the dominant player in the
global Herpes Zoster Infection Treatment Market in 2022, holding the largest market share. The
region has well-established vaccination programs, including the introduction of
vaccines like Zostavax and Shingrix for herpes zoster prevention. These
vaccines have been widely adopted and recommended for older adults, further
bolstering the market. North America is a hub for pharmaceutical research and
development. Pharmaceutical companies in the region continually invest in the
development of new herpes zoster treatments and vaccines, contributing to
market growth and innovation. Many individuals in North America have access to
health insurance, which helps cover the costs of medical care and prescription
medications. This insurance coverage reduces financial barriers to seeking
treatment for herpes zoster.
Major companies operating in Global Herpes Zoster
Infection Treatment Market are:
- GSK plc.
- Bausch Health
Companies Inc.
- Renata Limited
- Novan, Inc.
- Teva Pharmaceuticals
USA, Inc.
- Pfizer Inc.
- Apotex Inc.
- Sandoz Canada Inc.
- Novartis
Pharmaceuticals Corporation
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global
Herpes Zoster Infection Treatment Market is poised for significant growth in
the coming years due to several key factors. Firstly, the aging global
population is expanding, leading to a higher incidence of herpes zoster cases
as the elderly are more susceptible. Secondly, increased awareness and
education about herpes zoster, its complications, and the importance of early
treatment are encouraging individuals to seek medical care, driving market
demand. Thirdly, ongoing advancements in treatment options, including antiviral
medications and vaccines, are offering more effective and accessible solutions
for managing and preventing herpes zoster infections. Additionally, the high
economic burden of the disease is prompting investments in research and
development, spurring innovation in treatment modalities.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Herpes Zoster Infection Treatment Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Treatment Type (Prescription
Treatment, Supporting Treatment), By Route of administration (Oral,
Intravenous, Others), By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies) By Region and Competition”, has evaluated
the future growth potential of Global Herpes Zoster Infection Treatment Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Herpes Zoster Infection Treatment Market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com